Literature DB >> 17416749

Distinct mechanisms for trans-mediated mobilization of cellular RNAs by the LINE-1 reverse transcriptase.

José L Garcia-Perez1, Aurélien J Doucet, Alain Bucheton, John V Moran, Nicolas Gilbert.   

Abstract

Long Interspersed Element-1 (LINE-1 or L1) sequences comprise approximately 17% of human DNA and ongoing L1 retrotransposition continues to impact genome evolution. The L1-encoded proteins also can mobilize other cellular RNAs (e.g., Alu retrotransposons, SVA retrotransposons, and U6 snRNAs), which comprise approximately 13% of human DNA. Here, we demonstrate that the trans-mediated mobilization of non-L1 RNAs can occur by either template choice or template-switching mechanisms. Remarkably, these mechanisms are not mutually exclusive, as both processes can operate sequentially on the same RNA template. Finally, we provide evidence that efficient U6 snRNA retrotransposition requires both ORF1p and ORF2p, providing indirect evidence for the action of ORF1p in U6 snRNA retrotransposition. Thus, we propose that the LINE-1-encoded reverse transcriptase can mediate the retrotransposition of non-L1 RNAs by distinct mechanisms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17416749      PMCID: PMC1855177          DOI: 10.1101/gr.5870107

Source DB:  PubMed          Journal:  Genome Res        ISSN: 1088-9051            Impact factor:   9.043


  57 in total

1.  Genomes were forged by massive bombardments with retroelements and retrosequences.

Authors:  J Brosius
Journal:  Genetica       Date:  1999       Impact factor: 1.082

2.  Hot L1s account for the bulk of retrotransposition in the human population.

Authors:  Brook Brouha; Joshua Schustak; Richard M Badge; Sheila Lutz-Prigge; Alexander H Farley; John V Moran; Haig H Kazazian
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-07       Impact factor: 11.205

3.  SVA elements: a hominid-specific retroposon family.

Authors:  Hui Wang; Jinchuan Xing; Deepak Grover; Dale J Hedges; Kyudong Han; Jerilyn A Walker; Mark A Batzer
Journal:  J Mol Biol       Date:  2005-10-19       Impact factor: 5.469

4.  Ribonucleoprotein particle formation is necessary but not sufficient for LINE-1 retrotransposition.

Authors:  Deanna A Kulpa; John V Moran
Journal:  Hum Mol Genet       Date:  2005-09-23       Impact factor: 6.150

Review 5.  RNA-quality control by the exosome.

Authors:  Jonathan Houseley; John LaCava; David Tollervey
Journal:  Nat Rev Mol Cell Biol       Date:  2006-07       Impact factor: 94.444

6.  Cis-preferential LINE-1 reverse transcriptase activity in ribonucleoprotein particles.

Authors:  Deanna A Kulpa; John V Moran
Journal:  Nat Struct Mol Biol       Date:  2006-06-18       Impact factor: 15.369

7.  Cellular inhibitors of long interspersed element 1 and Alu retrotransposition.

Authors:  Hal P Bogerd; Heather L Wiegand; Amy E Hulme; José L Garcia-Perez; K Sue O'Shea; John V Moran; Bryan R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-25       Impact factor: 11.205

8.  Human L1 element target-primed reverse transcription in vitro.

Authors:  Gregory J Cost; Qinghua Feng; Alain Jacquier; Jef D Boeke
Journal:  EMBO J       Date:  2002-11-01       Impact factor: 11.598

9.  The human genome contains many types of chimeric retrogenes generated through in vivo RNA recombination.

Authors:  Anton Buzdin; Elena Gogvadze; Elena Kovalskaya; Pavel Volchkov; Svetlana Ustyugova; Anna Illarionova; Alexey Fushan; Tatiana Vinogradova; Eugene Sverdlov
Journal:  Nucleic Acids Res       Date:  2003-08-01       Impact factor: 16.971

10.  Mammalian small nucleolar RNAs are mobile genetic elements.

Authors:  Michel J Weber
Journal:  PLoS Genet       Date:  2006-10-20       Impact factor: 5.917

View more
  70 in total

1.  Retrotransposition of marked SVA elements by human L1s in cultured cells.

Authors:  Dustin C Hancks; John L Goodier; Prabhat K Mandal; Ling E Cheung; Haig H Kazazian
Journal:  Hum Mol Genet       Date:  2011-06-02       Impact factor: 6.150

Review 2.  Active human retrotransposons: variation and disease.

Authors:  Dustin C Hancks; Haig H Kazazian
Journal:  Curr Opin Genet Dev       Date:  2012-03-08       Impact factor: 5.578

3.  Similarities between long interspersed element-1 (LINE-1) reverse transcriptase and telomerase.

Authors:  Huira C Kopera; John B Moldovan; Tammy A Morrish; Jose Luis Garcia-Perez; John V Moran
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-22       Impact factor: 11.205

4.  Reprogramming somatic cells into iPS cells activates LINE-1 retroelement mobility.

Authors:  Silke Wissing; Martin Muñoz-Lopez; Angela Macia; Zhiyuan Yang; Mauricio Montano; William Collins; Jose Luis Garcia-Perez; John V Moran; Warner C Greene
Journal:  Hum Mol Genet       Date:  2011-10-11       Impact factor: 6.150

5.  Living fossil or evolving virus?

Authors:  Keizo Tomonaga
Journal:  EMBO Rep       Date:  2010-05       Impact factor: 8.807

6.  Epigenetic control of retrotransposon expression in human embryonic stem cells.

Authors:  Angela Macia; Martin Muñoz-Lopez; Jose Luis Cortes; Robert K Hastings; Santiago Morell; Gema Lucena-Aguilar; Juan Antonio Marchal; Richard M Badge; Jose Luis Garcia-Perez
Journal:  Mol Cell Biol       Date:  2010-11-01       Impact factor: 4.272

7.  Drawing a fine line on endogenous retroelement activity.

Authors:  Nathaly Castro-Diaz; Marc Friedli; Didier Trono
Journal:  Mob Genet Elements       Date:  2015-02-03

Review 8.  Epigenetic principles and mechanisms underlying nervous system functions in health and disease.

Authors:  Mark F Mehler
Journal:  Prog Neurobiol       Date:  2008-10-17       Impact factor: 11.685

9.  LINE-like retrotransposition in Saccharomyces cerevisiae.

Authors:  Chun Dong; Russell T Poulter; Jeffrey S Han
Journal:  Genetics       Date:  2008-10-28       Impact factor: 4.562

10.  An alternative pathway for Alu retrotransposition suggests a role in DNA double-strand break repair.

Authors:  Deepa Srikanta; Shurjo K Sen; Charles T Huang; Erin M Conlin; Ryan M Rhodes; Mark A Batzer
Journal:  Genomics       Date:  2008-11-11       Impact factor: 5.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.